Fig. 4

(A). Comparison of SUV_Top between immunocompromised and immunocompetent patients. (B). Comparison of SUR_Liver between the localized pulmonary diseases group and the disseminated diseases group. (C). Comparison of SUR_Blood between the localized pulmonary diseases group and the disseminated diseases group. (D). Comparison of SUV_Marrow between severe NTM-PD and non-severe NTM-PD. (E). Comparison of SUV_I−Lung between severe NTM-PD and non-severe NTM-PD. (F). Comparison of platelet count between severe NTM-PD and non-severe NTM-PD. (G). ROC curve analysis for predicting immunocompromised status in NTM patients using SUV_Top values of ¹⁸F-FDG-PET/CT scans. (H). ROC curve analysis for predicting disseminated NTM infection using SUR_Liver and SUR_Blood values of ¹⁸F-FDG-PET/CT scans. (I). Receiver operating characteristic curve (ROC) analysis for predicting severe NTM-PD using platelet count, and SUV_Marrow, and SUV_I−Lung values of ¹⁸F-FDG-PET/CT scans